入局、研修のご案内

業 績


  ■ 2000年   ■ 2001年   ■ 2002年   ■ 2003年   ■ 2004年   ■ 2005年   ■ 2006年   ■ 2007年
  ■ 2008年   ■ 2009年   ■ 2010年   ■ 2011年   ■ 2012年   ■ 2013年   ■ 2014年   ■ 2015年
  ■ 2016年   ■ 2017年   ■ 2018年   ■ 2019年   ■ 2020年   ■ 2021年   ■ 2022年   ■ 2023年
  ■ 2024年   ■ 2025年   ■   ■   ■   ■   ■   ■

■ Neuro-Tokushima achievements 2017

 

1 論文・著書など（アルファベット順または五十音順）
1A 英文
1A-a. 原著

  1. Abe T, Kawarai T, Fujita K, Sako W, Terasawa Y, Matsuda T, Sakai W, Tsukamoto-Miyashiro A, Matsui N, Izumi Y, Kaji R, Harada M. MR Spectroscopy in Patients with Hereditary Diffuse Leukoencephalopathy with Spheroids and Asymptomatic Carriers of Colony-stimulating Factor 1 Receptor Mutation. Magn Reson Med Sci 2017;16(4):297-303.

  2. Aoki J, Kimura K, Morita N, Harada M, Metoki N, Tateishi Y, Todo K, Yamagami H, Hayashi K, Terasawa Y, Fujita K, Yamamoto N, Deguchi I, Tanahashi N, Inoue T, Iwanaga T, Kaneko N, Mitsumura H, Iguchi Y, Ueno Y, Kuramoto Y, Ogata T, Fujimoto S, Yokoyama M, Nagahiro S; YAMATO Study Investigators. YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy). Stroke 2017;48(3):712-719.

  3. Banzrai C, Nodera H, Okada R, Higashi S, Osaki Y, Kaji R. Modification of multiple ion channel functions in vivo by pharmacological inhibition: observation by threshold tracking and modeling. J Med Invest 2017;64(1.2):30-38.

  4. Carandang MAE, Takamatsu N, Nodera H, Mori A, Mimura N, Okada N, Kinoshita H, Kuzuya A, Urushitani M, Takahashi R, Izumi Y, Kaji R. Velocity of intraneural blood flow is increased in inflammatory neuropathies: sonographic observation. J Neurol Neurosurg Psychiatry 2017;88(5):455-457.

  5. Fujita K, Eidelberg D. Imbalance of the direct and indirect pathways in focal dystonia: a balanced view. Brain 2017;140(12):3075-3077.

  6. Fujita K, Osaki Y, Miyamoto R, Shimatani Y, Abe T, Sumikura H, Murayama S, Izumi Y, Kaji R. Neurological attack and dynamic perfusion abnormality in neuronal intranuclear inclusion disease. Neurol Clin Pract 2017;7(6):e39-e42.

  7. Hioka A, Mizobuchi Y, Tada Y, Nishi K, Shirayama Y, Katoh S, Akazawa N, Kaji R, Ojima Y, Nagahiro S. Usefulness of a novel higher brain dysfunction screening test for evaluating higher brain function in healthy persons. J Med Invest 2017;64(3.4):280-285.

  8. Hiraoka A, Yoshikawa M, Nakamori M, Hosomi N, Nagasaki T, Mori T, Oda M, Maruyama H, Yoshida M, Izumi Y, Matsumoto M, Tsuga K. Maximum Tongue Pressure is Associated with Swallowing Dysfunction in ALS Patients. Dysphagia 2017;32(4):542-547.

  9. Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Hosokawa M, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci Transl Med 2017;9(391):eaaf3962.

  10. Kanematsu Y, Satomi J, Kuwayama K, Yamaguchi I, Yoshioka S, Kinouchi T, Tada Y, Yamamoto N, Matsubara S, Satoh K, Nagahiro S. Treatment Outcome of Carotid Artery Stenting Underwent within 14 Days of Stroke Onset - Consideration of Safety and Efficacy of Urgent Carotid Artery Stenting for Neurologically Progressing Patients. Neurol Med Chir (Tokyo) 2017;57(6):278-283.

  11. Kawarai T, Montecchiani C, Miyamoto R, Gaudiello F, Caltagirone C, Izumi Y, Kaji R, Orlacchio A. Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability. J Neurol Sci 2017;380:92-97.

  12. Kuwabara S, Mori M, Misawa S, Suzuki M, Nishiyama K, Mutoh T, Doi S, Kokubun N, Kamijo M, Yoshikawa H, Abe K, Nishida Y, Okada K, Sekiguchi K, Sakamoto K, Kusunoki S, Sobue G, Kaji R; Glovenin-I CIDP Study Group. Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry 2017;88(10):832-838.

  13. Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, Woltjen K, Nakagawa M, Asada T, Arai T, Kawakatsu S, Izumi Y, Kaji R, Iwata N, Inoue H. iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease. Cell Rep 2017;21(8):2304-2312.

  14. Konno T, Yoshida K, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda SI, Nishizawa M, Onodera O, Wszolek ZK, Ikeuchi T. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation. Eur J Neurol 2017;24(1):37-45.

  15. Lerner RP, Francardo V, Fujita K, Bimpisidis Z, Jourdain VA, Tang CC, Dewey SL, Chaly T, Cenci Nison MA, Eidelberg D. Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia. Sci Rep 2017;7(1):16005.

  16. Maki-Kuroda Y, Fujimoto M, Nagahama K, Kaji R, Mitsui T. Gene analysis of familial Parkinson's disease in Tokushima National Hospital: Results in 2016. Journal of Tokushima National Hospital 2017;8:20-22.

  17. Matsumoto S, Murakami N, Koizumi H, Takahashi M, Izumi Y, Kaji R. Evaluation of the Edrophonium Challenge Test for Cervical Dystonia. Intern Med 2017;56(18):2415-2421.

  18. Matsuzono K, Imamura K, Murakami N, Tsukita K, Yamamoto T, Izumi Y, Kaji R, Ohta Y, Yamashita T, Abe K, Inoue H. Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs. Mol Ther Nucleic Acids 2017;8:211-219.

  19. Murakami N, Imamura K, Izumi Y, Egawa N, Tsukita K, Enami T, Yamamoto T, Kawarai T, Kaji R, Inoue H. Proteasome impairment in neural cells derived from HMSN-P patient iPSCs. Mol Brain 2017;10(1):7.

  20. Murakami N, Ishikawa T, Kondo T, Imamura K, Tsukita K, Enami T, Funayama M, Shibukawa R, Matsumoto S, Izumi Y, Ohta E, Obata F, Kaji R, Inoue H. Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation. Stem Cell Res 2017;24:36-39.

  21. Murata-Shinozaki Y, Takahashi T, Matsubara T, Maruyama H, Izumi Y, Matsumoto M. The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway. Neurosci Lett 2017;638:55-59.

  22. Muto K, Matsui N, Unai Y, Sakai W, Haji S, Udaka K, Miki H, Furukawa T, Abe M, Kaji R. Memory B cell resurgence requires repeated rituximab in myasthenia gravis. Neuromuscular Disorders 2017;27(10):918-922.

  23. Nakane S, Furutani K, Harada M, Urushihara R, Matsui N, Izumi Y, Kaji R. Multimodal analysis based on high‐field magnetic resonance and motor evoked potentials: A case report of multiple sclerosis. Clin Exp Neuroimmunol 2017;8(1):43-46.

  24. Sako W, Abe T, Izumi Y, Yamazaki H, Matsui N, Harada M, Kaji R. Spontaneous brain activity in the sensorimotor cortex in amyotrophic lateral sclerosis can be negatively regulated by corticospinal fiber integrity. Neurol Sci 2017;38(5):755-760.

  25. Sako W, Murakami N, Izumi Y, Kaji R. Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis. J Neurol Sci 2017;378:153-157.

  26. Sako W, Murakami N, Motohama K, Izumi Y, Kaji R. The effect of istradefylline for Parkinson’s disease: A meta-analysis. Sci Rep 2017;7(1):18018.

  27. Sekine SI, Kondo T, Murakami N, Imamura K, Enami T, Shibukawa R, Tsukita K, Funayama M, Inden M, Kurita H, Hozumi I, Inoue H. Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene. Stem Cell Res 2017;24:40-43.

  28. Shimitani Y, Naka Y, Sato K, Shibata H. Pneumococcal meningitis in hyposplenism. Neurol Clin Neurosci 2017;5(1):42.

  29. Shono K, Satomi J, Tada Y, Kanematsu Y, Yamamoto N, Izumi Y, Kaji R, Harada M, Nagahiro S. Optimal Timing of Diffusion-Weighted Imaging to Avoid False-Negative Findings in Patients With Transient Ischemic Attack. Stroke 2017;48(7):1990-1992.

  30. Sogabe S, Satomi J, Tada Y, Kanematsu Y, Kuwayama K, Yagi K, Yoshioka S, Mizobuchi Y, Mure H, Yamaguchi I, Abe T, Yamamoto N, Kitazato KT, Kaji R, Harada M, Nagahiro S. Intra-arterial high signals on arterial spin labeling perfusion images predict the occluded internal carotid artery segment. Neuroradiology 2017;59(6):587-595.

  31. Sogawa K, Nodera H, Takamatsu N, Mori A, Yamazaki H, Shimatani Y, Izumi Y, Kaji R. Neurogenic and Myogenic Diseases: Quantitative Texture Analysis of Muscle US Data for Differentiation. Radiology 2017;283(2):492-498.

  32. Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Higuchi I, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M. Multicenter questionnaire survey for sporadic inclusion body myositis in Japan. Orphanet J Rare Dis 2016;11(1):146.

  33. Takamatsu N, Sogawa K, Nodera H, Hashiguchi S, Osaki Y, Saito M, Mori A, Izumi Y, Kaji R. Preferential changes of skeletal muscle echogenicity in myotonic dystrophy type 1. Eur J Neurol 2017;24(2):366-373.

  34. Tan GW, Kondo T, Murakami N, Imamura K, Enami T, Tsukita K, Shibukawa R, Funayama M, Matsumoto R, Ikeda A, Takahashi R, Inoue H. Induced pluripotent stem cells derived from an autosomal dominant lateral temporal epilepsy (ADLTE) patient carrying S473L mutation in leucine-rich glioma inactivated 1 (LGI1). Stem Cell Res 2017;24:12-15.

  35. Tiribuzi R, Crispoltoni L, Chiurchiù V, Casella A, Montecchiani C, Del Pino AM, Maccarrone M, Palmerini CA, Caltagirone C, Kawarai T, Orlacchio A, Orlacchio A. Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients. J Neurol Sci 2017;372:408-412.

  36. Tsukamoto A, Osaki H, Izumi Y, Kaji R, Mitsui T. Progressive supranuclear palsy complicated with Lambert-Eaton myasthenic syndrome : report of a case. Journal of Tokushima National Hospital 2017;8:6-8.

  37. Uyama N, Otsuka H, Shinya T, Otomi Y, Harada M, Sako W, Izumi Y, Kaji R, Watanabe Y, Takashi S, Kunikane Y. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes. Nucl Med Commun 2017;38(6):487-492.

  38. Vo A, Sako W, Fujita K, Peng S, Mattis PJ, Skidmore FM, Ma Y, Uluğ AM, Eidelberg D. Parkinson's disease-related network topographies characterized with resting state functional MRI. Hum Brain Mapp 2017;38(2):617-630.

  39. Yamagishi Y, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, Chiba A, Kaji R, Kanda T, Kaida K, Ikeda SI, Mutoh T, Yamasaki R, Takashima H, Matsui M, Nishiyama K, Sobue G, Kusunoki S. Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst 2017;22(4):433-439.

  40. Yamamoto N, Satomi J, Yamamoto Yuki, Izumi Y, Nagahiro S, Kaji R. Usefulness of 3-tesla magnetic resonance arterial spin-labeled imaging for diagnosis of cranial dural arteriovenous fistula. J Neurol Sci 2017;372:428-432.

  41. Yamamoto N, Satomi J, Yamamoto Yuki, Shono K, Kanematsu Y, Izumi Y, Nagahiro S, Kaji R. Risk Factors of Neurological Deterioration in Patients with Cerebral Infarction due to Large-Artery Atherosclerosis. J Stroke Cerebrovasc Dis 2017;26(8):1801-1806.

  42. Yoshimoto S, Nagai K, Shibata E, Ueda S, Ono H, Tamaki M, Nishimura K, Obata F, Inagaki T, Minato M, Kishi F, Matsuura M, Matsui N, Endo I, Hann M, Kishi S, Murakami T, Abe H, Doi T. Influential factors on serum albumin concentration in hospitalized chronic kidney disease patients. J Med Invest 2017;64(1.2):146-152.

1A-b. 総説

  1. Dressler D, Bhidayasiri R, Bohlega S, Chahidi A, Chung TM, Ebke M, Jacinto LJ, Kaji R, Koçer S, Kanovsky P, Micheli F, Orlova O, Paus S, Pirtosek Z, Relja M, Rosales RL, Sagástegui-Rodríguez JA, Schoenle PW, Shahidi GA, Timerbaeva S, Walter U, Saberi FA. Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force. J Neurol 2017;264(1):112-120.

  2. Kawarai T, Morigaki R, Kaji R, Goto S. Clinicopathological Phenotype and Genetics of X-Linked Dystonia–Parkinsonism (XDP; DYT3; Lubag). Brain Sci 2017;7(7):E7.

1A-c. 症例報告

  1. Nakane S, Furutani K, Harada M, Urushihara R, Matsui N, Izumi Y, Kaji R. Multimodal analysis based on high-field magnetic resonance and motor evoked potentials: A case report of multiple sclerosis. Clinical and Experimental Neuroimmunology 2017;8(1):43-46.